Showing results (811-820 of 2,003) with videos related to

Sort By:
Pageof 201
Endocrine, Metabolic & Immune Disorders Drug Targets|April 30, 2026
Association Between Skeletal Muscle Mass to Visceral Fat Area Ratio and Hypertension: Mediation Analysis Involving Body Mass Index in the NHANESJuanjuan Fang, Zhenhua Wang, Apang Du, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|May 5, 2026
DHEAS Elevation as the Early Biochemical Abnormality in ACTH-Secreting Pituitary Microadenomas in Children: Two Case ReportsQiting Zhang, Yiling Cui, Wenjun Long, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 15, 2026
Vitamin D Supplementation Improves Serological Parameters and Recovery Outcomes in COVID-19 PatientsZhaoying Chen, Jianping Sheng, Qihang Ma, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|September 3, 2020
Vitamin B12 Deficiency Among the Healthy Jordanian Adult Population: Diagnostic Levels, Symptomology and Risk FactorsAmer Abu-Shanab, Malek Zihlif, Momen N Rbeihat, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 7, 2017
Independent Relationship of Osteocalcin Circulating Levels with Obesity, Type 2 Diabetes, Hypertension, and HDL CholesterolGiovanni De Pergola, Vincenzo Triggiani, Nicola Bartolomeo, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 1, 2014
Assessment of a synthetic steroid and flutamide on dopamine, GSH and H2O2 levels in rat brain in presence of fructoseDavid C Guzman, Eugene Bratoeff, Aylin S Ortiz, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|April 10, 2014
Amiodarone-induced SIADH: two cases reportMichele Iovino, Nicola Iovine, Antonio Petrosino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|December 7, 2016
A Glycemic Threshold of 90 mg/dl Promotes Early Signs of Atherosclerosis in Apparetly Healthy Overweight/Obese SubjectsMarco Matteo Ciccone, Francesca Cortese, Michele Gesualdo, et al.
Pageof 201